Jury backs Johnson & Johnson in stent patent row with Boston
This article was originally published in Clinica
Executive Summary
A district court jury in Delaware has agreed with Johnson & Johnson's Cordis unit that stents made by Boston Scientific infringe its patents. Analysts had seen the ruling as a foregone conclusion, given the outcomes of earlier litigation against Boston Scientific and Medtronic involving one of the patents, the '762 or Palmaz patent covering balloon expandable stents.